Male Gonorrhea: Symptoms, Incubation Period, Treatment & Risks of Untreated Infection | Doctor-Reviewed STI Guide [2026]

What is male gonorrhea: causative organism, transmission routes, and epidemiology

Gonorrhea is a sexually transmitted infection caused by Neisseria gonorrhoeae, a Gram-negative diplococcus that infects mucous membranes. It is also called "gonococcal infection" and is classified as a category V notifiable disease (sentinel surveillance) under Japan's Infectious Diseases Control Law.

N. gonorrhoeae is an extremely fragile organism that can only survive on the surface of mucous membranes. It is highly susceptible to drying, temperature change, and disinfectants, so transmission via toilet seats or shared towels in everyday life is virtually nonexistent. Transmission occurs almost exclusively through direct mucosal contact during sexual activity (vaginal, oral, or anal intercourse).

In men, the primary sites of infection are the urethra, pharynx, and rectum, and symptoms vary considerably depending on the site. Pharyngeal and rectal infections in particular tend to produce few or no symptoms, so the infection can spread unknowingly to others.

Transmission routes: probability of infection per sexual act

Gonorrhea is highly infectious. The probability of male infection from a single act of intercourse with an infected partner is 20-30%, while the probability of female infection is 50-70% (WHO and CDC data). There are only three routes of transmission:

• Vaginal intercourse: The most common route. 20-30% of men become infected after a single act of unprotected vaginal intercourse with an infected partner.
• Oral sex: Fellatio and cunnilingus can transmit pharyngeal or urethral gonorrhea. Because symptoms are mild, the pharynx easily becomes a hidden source of infection.
• Anal intercourse: The main route for rectal gonorrhea. This is especially important for men who have sex with men (MSM).

Correct condom use significantly reduces transmission risk, but few people use condoms during oral sex, which is why the pharynx has become an important reservoir for infection. If you develop symptoms after intercourse with a casual partner, you should be tested promptly.

Epidemiology of gonorrhea in Japan: trends in the 2020s

According to the Ministry of Health, Labour and Welfare's National Epidemiological Surveillance of Infectious Diseases, the number of gonococcal infections per sentinel site in Japan has been rising in the 2020s compared with the 2010s. Most cases occur in men in their 20s and 30s, with the following features:

• The male-to-female ratio is roughly 3:1 (men are more likely to be diagnosed because their symptoms are more pronounced).
• People in their 20s and 30s account for about 60-70% of all cases.
• Many cases are linked to the sex industry.
• Reports of antimicrobial-resistant N. gonorrhoeae are increasing year over year.

Many infections occur outside sentinel facilities, and the true number of cases is estimated to be 3-10 times the reported figure. Coinfection with chlamydia is found in 20-30% of cases, so chlamydia testing is also recommended when gonorrhea is diagnosed.

Symptoms of male gonorrhea: urethritis, purulent discharge, and dysuria

Symptoms of male gonorrhea differ markedly by site of infection. In the most common form, gonococcal urethritis, purulent discharge and severe pain on urination are the hallmark symptoms. In contrast, pharyngeal and rectal infections produce few symptoms and are easily missed.

Below we organize the symptoms by site and explain how to spot the infection early.

Classic symptoms of gonococcal urethritis: discharge and dysuria

The classic symptoms of gonococcal urethritis, the most common form in men, are as follows. They appear rapidly 2-7 days after exposure and are typically more severe than in chlamydial urethritis.

• Urethral discharge (pus): A sticky yellow-white to yellow-green discharge appears spontaneously at the urethral opening and often stains underwear. Whereas chlamydia produces a clear to milky discharge, gonorrhea produces a purulent discharge in larger amounts.
• Severe pain on urination (burning): A burning or stabbing pain during urination, due to inflammation of the urethral lining. It is especially severe at the start of urination.
• Itching or discomfort in the urethra: Early on, the infection may begin as mild itching or vague discomfort.
• Redness and swelling at the urethral opening: The meatus becomes red and swollen and tender to the touch.
• Frequent urination: Patients tend to urinate small amounts more often in an attempt to avoid the pain.

These symptoms typically appear suddenly 2-7 days after exposure. Because the discomfort is intense, men are usually motivated to seek care. If symptoms appear, see a doctor immediately. Over-the-counter medicines cannot cure the infection.

How to tell gonorrhea and chlamydia apart in men

Gonococcal urethritis in men can resemble chlamydial urethritis, but there are several differences. Confirmatory diagnosis requires laboratory testing; the table below is provided only as a reference.

Symptoms alone are not enough for a definitive diagnosis, so the causative pathogen must be identified by testing before treatment is started. Because the effective antibiotics differ, the wrong choice of treatment will not work.

The pitfall of asymptomatic gonorrhea: infection without symptoms

Gonococcal urethritis in men typically causes prominent symptoms, but 10-20% of infected men have no symptoms or only minimal symptoms. Even without symptoms, they can transmit the infection to others, and the organism continues to spread within their own body. Care is needed.

Pharyngeal and rectal gonorrhea are usually asymptomatic, so testing is recommended for the following situations even in the absence of symptoms:

• Unprotected sex with a casual partner.
• A partner has been diagnosed with gonorrhea.
• You have had oral or anal sex.
• You have urethral discomfort or mild itching.

Do not assume "no symptoms means I'm fine." If you have any concern, getting tested is the most reliable way to break the chain of transmission.

Incubation period and clinical course of gonorrhea

The incubation period for gonorrhea is 2-7 days (average 3-5 days), which is relatively short among sexually transmitted infections. Symptoms appear earlier than with chlamydia (1-3 weeks) or syphilis (about 3 weeks). This reflects the rapid replication of N. gonorrhoeae.

Individual variation exists depending on host immunity and inoculum size, and some cases develop symptoms as late as 14 days after exposure. Even if you suspect a recent exposure but have no symptoms yet, you may still be within the incubation period and should monitor for symptoms.

Timeline from infection to symptoms and complications

The clinical course after gonococcal infection can be summarized as follows.

In men, symptoms are usually severe enough that patients seek care at the onset of disease. However, leaving the infection untreated or using over-the-counter medicines on your own allows the disease to progress to complications. Ideally, see a doctor within 2-3 days of symptom onset.

Risks of untreated gonorrhea: epididymitis, infertility, and arthritis

If male gonorrhea is left untreated, it can cause serious complications such as epididymitis, prostatitis, infertility, and disseminated gonococcal infection. The initial urethral symptoms may resolve on their own, but this is not a cure; it is a sign that the bacteria have spread deeper into the body.

Below we describe the major complications that occur when gonorrhea is left untreated.

Risk 1: Epididymitis and male infertility

Epididymitis is a complication in which N. gonorrhoeae ascends retrograde from the urethra through the vas deferens to inflame the epididymis. It develops in roughly 1-2% of men with untreated gonorrhea.

• Symptoms: Marked swelling and pain of the scrotum, fever of 38 degrees C or higher, swollen inguinal lymph nodes, and difficulty walking.
• Diagnosis: Ultrasound confirms enlargement of the epididymis. Blood tests show elevated CRP.
• Treatment: Long-course antibiotics (ceftriaxone plus doxycycline) and rest.

The most serious sequela is scarring and obstruction of the vas deferens. Bilateral disease can obstruct the passage of sperm, causing obstructive azoospermia, which is a form of male infertility. Once scarring has occurred, it cannot be reversed, so early treatment to prevent progression to epididymitis is critically important.

Risk 2: Prostatitis and seminal vesiculitis: chronic pelvic pain

When N. gonorrhoeae spreads from the urethra to the prostate and seminal vesicles, it can cause acute prostatitis and seminal vesiculitis. Symptoms include:

• Pain or discomfort in the perineum (between the anus and the scrotum).
• Lower abdominal pain and lower back pain.
• Worsening pain on urination and a sense of incomplete emptying.
• Pain on ejaculation and blood in the semen (hematospermia).
• Fever of 38-39 degrees C and general fatigue.

If the acute phase is left untreated, it can progress to chronic prostatitis and, over months to years, evolve into chronic pelvic pain syndrome (CPPS). Once chronic, treatment becomes difficult, which is why early antibiotic therapy is important.

Risk 3: Disseminated gonococcal infection (DGI): arthritis, skin lesions, and sepsis

When N. gonorrhoeae spreads throughout the body via the bloodstream, a serious condition called Disseminated Gonococcal Infection (DGI) can develop. It occurs in 0.5-3% of patients with gonorrhea and is characterized by the following triad:

• Arthritis and tenosynovitis: Acute arthritis in large joints such as the knees, wrists, and ankles, with swelling, pain, and limited range of motion.
• Skin lesions: Small petechiae, pustules, or purpura appear on the distal extremities.
• Fever: Persistent fever of 38-39 degrees C.

Rarely, endocarditis or meningitis can complicate DGI, and hospitalization for intravenous therapy is required. DGI can develop without any urethritis symptoms, so diagnosis is often delayed. There are reports of patients who visited an orthopedic clinic with a swollen joint and fever and were eventually found to have gonococcal arthritis.

Risk 4: Increased risk of HIV and other STIs

Mucosal inflammation from gonorrhea has been shown in epidemiologic studies to raise the risk of HIV, syphilis, and hepatitis B by 3-5 fold. This is because disruption of the mucosal barrier makes it easier for viruses to enter.

When gonorrhea is diagnosed, standard practice is to simultaneously test for HIV, syphilis, chlamydia, and hepatitis B and C. At Men's Care Clinic we also recommend a bundled STI panel.

Pharyngeal and rectal gonorrhea: beware of asymptomatic infection

N. gonorrhoeae can also infect the pharynx (throat) and rectum through oral or anal sex. Infections at these sites typically produce few or no symptoms, making them important reservoirs for ongoing transmission in the community.

For details on pharyngeal gonorrhea see Male pharyngeal gonorrhea: symptoms, testing, and treatment.

Pharyngeal gonorrhea: missed because the only sign is mild throat discomfort

Pharyngeal gonorrhea is infection of the oral cavity and throat with N. gonorrhoeae through oral sex such as fellatio. It has the following features:

• About 90% are asymptomatic: Most infections produce no noticeable symptoms.
• Mild throat discomfort: Slight sore throat or scratchiness, indistinguishable from a common cold.
• A source of infection for partners: Can transmit urethral gonorrhea via oral sex.
• Delayed diagnosis: Often treated as a cold or gargled away with antiseptic mouthwashes, leading to worsening disease.

Pharyngeal gonorrhea cannot be cured with ordinary antibiotic gargles; intravenous ceftriaxone is required. For more details see the article on pharyngeal gonorrhea.

Rectal gonorrhea: infection from anal sex

Rectal gonorrhea is infection of the rectal mucosa with N. gonorrhoeae through anal sex or shared sex toys. It is particularly common in men who have sex with men (MSM).

• Mostly asymptomatic.
• When symptoms occur: Anal discomfort or itching, mucous or purulent discharge from the anus, pain on defecation, and tenesmus (the feeling that stool remains).
• Often misdiagnosed as hemorrhoids or proctitis.

Diagnosis requires a rectal swab for PCR. Urine testing alone cannot detect rectal gonorrhea, so specimens must be collected from each potentially infected site.

Diagnostic tests for gonorrhea: PCR, culture, and differences in sensitivity

The standard test for diagnosing male gonorrhea is nucleic acid amplification testing (NAAT, commonly called PCR). With sensitivity and specificity both above 95%, it can detect even small numbers of organisms, making it the most reliable test available.

The appropriate test depends on when symptoms appeared and which site is affected.

Test methods and specimens by site

An important caveat: for urine testing, the first-catch urine should be collected at least 2 hours after the last void. If urine is sampled immediately after voiding, organisms can be washed away and the result may be falsely negative.

Because coinfection with chlamydia is common, PCR testing for chlamydia is performed at the same time using the same specimen as standard practice when gonorrhea is being investigated.

When to use PCR versus culture

PCR has become the mainstay in recent years, but with antimicrobial-resistant N. gonorrhoeae on the rise, culture remains important for treatment failures and complex cases.

• PCR (NAAT): Sensitivity and specificity above 95%. Quick turnaround. The optimal screening test regardless of symptoms.
• Culture: Sensitivity is lower than PCR, but it allows antimicrobial susceptibility testing, which is important for choosing therapy. Essential in cases of treatment failure.
• Gram-stained microscopy: Can suggest N. gonorrhoeae from urethral discharge in about 10 minutes. However, it is unreliable for pharyngeal specimens because of frequent false positives.

At Men's Care Clinic we use PCR testing as standard and add culture when indicated.

Treatment of gonorrhea: ceftriaxone infusion and antimicrobial resistance

The first-line treatment for male gonorrhea is a single intravenous dose of ceftriaxone 1 g. It is recommended by every major guideline, including the Japanese Society for Sexually Transmitted Infections, the U.S. CDC, and the WHO. Oral antibiotics are no longer recommended because of resistance concerns.

Treatment is completed in a single infusion, which keeps the number of clinic visits to a minimum.

First-line: ceftriaxone 1 g intravenous infusion

Ceftriaxone is a third-generation cephalosporin for injection and is one of the few agents that retains nearly 100% efficacy against N. gonorrhoeae.

• Dosage: Ceftriaxone 1 g in 100 mL of normal saline, infused over 30 minutes, single dose only.
• Test of cure: PCR repeat 2-4 weeks after treatment to confirm eradication.
• If coinfected with chlamydia: Add azithromycin 1 g orally or doxycycline 100 mg for 7 days.
• Side effects: Pain at the injection site, diarrhea, and rarely, allergic reactions.

For patients allergic to ceftriaxone, alternatives such as spectinomycin 2 g intramuscularly may be considered.

Why oral antibiotics no longer work: the threat of resistant gonorrhea

In the past, gonorrhea could be treated with oral penicillins, tetracyclines, and fluoroquinolones, but almost all of these are now ineffective due to resistance.

• Penicillins: Resistance emerged in the 1980s.
• Tetracyclines: Resistance emerged in the 1990s.
• Fluoroquinolones (e.g., levofloxacin): Resistance emerged in the 2000s; resistance rates in Japan are 70-80%.
• Cefixime (oral cephalosporin): Removed from the Japanese Society for Sexually Transmitted Infections recommendations in 2011.

The WHO has designated antimicrobial-resistant N. gonorrhoeae as a "high-priority pathogen", and ceftriaxone-resistant cases have been reported worldwide. For this reason, you must never self-medicate with antibiotics.

Precautions during and after treatment

• Abstinence: Avoid sexual activity for 2 weeks after treatment to prevent transmission to partners and reinfection.
• Treat partners at the same time: Sexual partners from the past 2 months should be tested and treated regardless of symptoms.
• Test of cure: PCR repeat 2-4 weeks after treatment to confirm eradication.
• Simultaneous testing for HIV and syphilis: Important to check for other STIs.
• Reinfection prevention: Use condoms correctly for all future sexual activity.

Even if symptoms resolve, do not stop treatment on your own. Follow your physician's instructions through to the test of cure.

Gonorrhea in the wider STI landscape: how it differs from chlamydia

Together with chlamydia, gonorrhea is one of the two leading STIs and accounts for the majority of male urethritis cases. Here we put gonorrhea in context by comparing it with other STIs.

For an overview of STIs and other sexually transmitted infections, see Male STIs: a comprehensive guide to types, symptoms, and treatment.

Comparison of major STIs and gonorrhea

The defining features of gonorrhea are its short incubation period and severe symptoms, which often lead to earlier detection than other STIs. However, pharyngeal and rectal gonorrhea cause few symptoms, which is why routine screening is important.

STI care at Men's Care Clinic

Men's Care Clinic operates three locations: Shimbashi, Akihabara, and Omotesando, and also offers online consultations. Through our medical partnership with Toyosu Hospital, we can also coordinate care smoothly when more specialized treatment is needed. We provide STI testing and treatment for gonorrhea and other infections with full attention to privacy.

The care pathway: from first consultation to treatment and test of cure

• STEP 1 – Book: Book on the web or by phone. Same-day and online appointments are available.
• STEP 2 – Interview and testing: A physician takes your history and orders the necessary tests (urine PCR, pharyngeal swab, rectal swab, blood tests, etc.).
• STEP 3 – Results: Results are available in 1-3 days and are communicated by phone or online.
• STEP 4 – Treatment: If gonorrhea is positive, ceftriaxone 1 g is administered by intravenous infusion (about 30 minutes).
• STEP 5 – Test of cure: A repeat PCR 2-4 weeks later confirms eradication.

All consultations take place in private rooms, and contact with other patients in the waiting area is kept to a minimum.

Online STI care: receive the test kit at home

With online STI care, the workflow is as follows:

• Book a video consultation on the web (often available the same day).
• A test kit is sent in discreet packaging.
• Collect your own sample and return it.
• If results are positive, a physician decides treatment via online consultation.
• Gonorrhea treatment (intravenous infusion) requires an in-person visit at the nearest clinic.

There are no initial or follow-up consultation fees. This service is ideal for those who feel uncomfortable visiting a clinic.

For gonorrhea testing and treatment, choose Men's Care Clinic

Treatment is completed with a single ceftriaxone 1 g infusion. Initial and follow-up consultations are free / Online consultation available

▶ See STI treatment details
▶ Consult online

Frequently asked questions about gonorrhea (FAQ)

Below, a Men's Care Clinic physician answers the questions most frequently asked by patients about gonorrhea.

Q1. Does gonorrhea go away on its own?

No, it almost never resolves on its own. The initial urethral symptoms may temporarily ease, but this is a sign that the bacteria have moved on from the urethra to the prostate, epididymis, and bloodstream. It is not a cure.

If left untreated, gonorrhea can cause serious complications such as epididymitis, male infertility, and disseminated gonococcal infection. You should always seek proper antibiotic treatment at a medical institution.

Q2. Can over-the-counter medicines or generic antibiotics cure gonorrhea?

No. Over-the-counter products and antibiotics bought online cannot treat gonorrhea. Current strains of N. gonorrhoeae are highly resistant to oral penicillins, tetracyclines, and fluoroquinolones, and the first-line treatment is a single intravenous dose of ceftriaxone 1 g.

Self-medicating with antibiotics can produce drug-resistant strains through inadequate treatment, or temporarily suppress symptoms so that you only seek care once the disease has worsened. Always see a doctor and receive proper treatment.

Q3. How long does treatment for gonorrhea take?

The treatment itself is completed in a single infusion. A 30-minute intravenous dose of ceftriaxone 1 g eradicates the infection in most patients.

After treatment, however, follow-up proceeds on the following schedule:

• From treatment to 2 weeks: Avoid sexual activity.
• 2-4 weeks later: PCR test of cure.
• Partner treatment: Partners must be tested and treated at the same time.

For pharyngeal or rectal infection, or when resistance is suspected, the duration of treatment and frequency of repeat testing may be increased.

Q4. What is the difference between gonorrhea and chlamydia?

Both gonorrhea and chlamydia are sexually transmitted urethritis, but the causative organism, incubation period, symptom severity, and treatment all differ.

• Gonorrhea: Caused by N. gonorrhoeae (bacterium). Incubation 2-7 days. Severe symptoms with abundant pus. Treated with intravenous ceftriaxone.
• Chlamydia: Caused by Chlamydia trachomatis (bacterium). Incubation 1-3 weeks. Mild symptoms with clear discharge. Treated with azithromycin or doxycycline.

Coinfection occurs in 20-30% of cases, so if either is positive, the standard approach is to treat for both. For more details, see the article on chlamydia.

Q5. When is the best time to be tested for gonorrhea?

If you have symptoms, seek care immediately. If you have no symptoms, testing is best done at least 2-3 days after the at-risk exposure. Immediately after exposure, the organism load may be too low and the test can be falsely negative.

For the most reliable confirmation, waiting about one week is ideal. If you have any concern, testing is recommended early, regardless of symptoms.

Q6. If I'm diagnosed with gonorrhea, should I tell my partner?

Yes. It is essential to inform your partner so that they can also be tested and treated. If you are treated but your partner remains infected, you can re-infect each other in a "ping-pong" pattern.

Ideally, you should contact every partner from the past 2 months, and testing and treatment are recommended even in the absence of symptoms. If you are unsure how to bring it up, your physician can offer advice on how to communicate the news. Please feel free to ask.

Q7. Can gonorrhea recur? How can it be prevented?

There is no protective immunity against gonorrhea, and you can be re-infected any number of times. Re-infection after successful treatment is not unusual. Key points for prevention include:

• Correct condom use: Use condoms for vaginal, oral, and anal sex.
• Avoid multiple casual partners: Limiting the number of partners reduces infection risk.
• Regular testing: Every 6-12 months, or every 3 months if you have multiple partners.
• Partner treatment: Treating partners simultaneously prevents ping-pong reinfection.

No vaccine is currently available, so prevention relies on correct condom use and regular testing.